VivoSeq
Other

Craniotomy

1

Pipeline Programs

0

Active Trials

2

Companies Involved

Craniotomy is an early-stage landscape with 1 program across 2 companies. The most active players are Kenvue Brands, Eli Lilly. 1 therapy is approved.

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

100/100

Completion Rate

100/100

Attrition Rate

0/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs

Trial Status

12

clinical trials

Completed12 · 100%

Trial Activity

12 trials

Desflurane and Brain Relaxation in Craniotomy
Completed··N/A·NCT04691128·111 enrolled
Nicardipine vs Esmolol Craniotomy Emergence
Completed·NNorthwestern University·Phase 1·NCT01951950·40 enrolled
The Efficacy of Scalp Block in Craniotomy
Completed··Phase 1·NCT06951230·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)